Abstract
Canadian practice guidelines recommend that ACE inhibitors (ACEIs) or angiotensin II receptor antagonists (ARBs) be used for vascular protection in people with diabetes at high risk of cardiovascular event including diabetics aged ≥65.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
